Recent Updates
Recently added Catalysts
CAPR

x4;Ɖƌŝů​Ϯϵ͕​ϮϬϮϰ EĂƐĚĂƋ͗​ WZ WͲϭϬϬϮ​&#

Monday, April 29, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: x4;Ɖƌŝů​Ϯϵ͕​ϮϬϮϰ EĂƐĚĂƋ͗​ WZ WͲϭϬϬϮ​D​WƌŽŐƌĂ&#x17
Price reaction · baseline $5.41 (2024-04-26 close) · clean, no other CAPR news in the window
day 0 close
-1.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+668%
120-day peak, hindsight
Typical move
11.2%
average across 10 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
Cenderitide
Phase 2 · Heart Failure

Full Press Release Details

x4;Ɖƌŝů​Ϯϵ͕​ϮϬϮϰ EĂƐĚĂƋ͗​ WZ WͲϭϬϬϮ​D​WƌŽŐƌĂŵ​ ϭϬϬϮ D WƌŽŐ hƉĚĂƚĞ​Ăůů​ ĂƉƌŝĐŽƌ​dŚĞƌĂƉĞƵƚŝĐƐ͕​/ŶĐ͘ ĞǀĞůŽƉŝŶŐ​dƌĂŶƐĨŽƌŵĂƚŝǀĞ​dŚĞƌĂƉŝĞƐ​ ĨƌŽŵ​ĞŶĐŚ​ƚŽ​ĞĚƐŝĚĞ &ŽƌǁĂƌĚ​ ŽŽŬŝŶŐ​ƚĂƚĞŵĞŶƚƐ​​ ƚĂƚĞŵĞŶƚƐ​ŝŶ ƚŚŝƐ​ƉƌĞƐĞŶƚĂƚŝŽŶ​ƌĞŐĂƌĚŝŶŐ​ƚŚĞ​ĞĨĨŝĐĂĐLJ͕​ƐĂĨĞƚLJ͕​ĂŶĚ​ŝŶƚĞŶĚĞĚ​ƵƚŝůŝnjĂƚŝŽŶ​ŽĨ​ĂƉƌŝĐŽƌ͛Ɛ​ƉƌŽĚƵĐƚ​ĐĂŶĚŝĚĂƚĞƐ͖​ƚŚĞ​ ŝŶŝƚŝĂƚŝŽŶ͕​ ĐŽŶĚƵĐƚ͕​ ƐŝnjĞ͕​ƚŝŵŝŶŐ​ĂŶĚ​ ƌĞƐƵůƚƐ​ ŽĨ​ ĚŝƐĐŽǀĞƌLJ​ĞĨĨŽƌƚƐ​ĂŶĚ​ ĐůŝŶŝĐĂů​ ƚƌŝĂůƐ͖​ ƚŚĞ​ ƉĂĐĞ​ ŽĨ​ĞŶƌŽůůŵĞŶƚ​ ŽĨ​ ĐůŝŶŝĐĂů​ ƚƌŝĂůƐ͖​ ƉůĂŶƐ​ƌĞŐĂƌĚŝŶŐ​ƌĞŐƵůĂƚŽƌLJ​ĨŝůŝŶŐƐ͕​ĨƵƚƵƌĞ​ƌĞƐĞĂƌĐŚ​ĂŶĚ​ĐůŝŶŝĐĂů​ƚƌŝĂůƐ͖​ƌĞŐƵůĂƚŽƌLJ​ĚĞǀĞůŽƉŵĞŶƚƐ​ŝŶǀŽůǀŝŶŐ​ƉƌŽĚƵĐƚƐ͕​ŝŶĐůƵĚŝŶŐ ƚŚĞ​ Ăďŝůŝƚ&
ShareAdd on Google
Tags: CAPR Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 29, 2024

Biotech snapshot

Cash runway
$238M liquidity · $10M/mo burn
~22 mo
Low dilution risk
Lead asset
CenderitidePhase 2
Heart Failure →

Catalyst track record

+668%
best trade around CAPR's most recent catalyst

Peak hindsight return over a 120-day window, across 10 tracked FDA/PDUFA catalysts for CAPR.

See every catalyst's timing & PoA →